WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 44 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $998,571 | -61.9% | 466,622 | -45.7% | 0.00% | 0.0% |
| Q2 2023 | $2,620,703 | +91757.8% | 859,247 | -21.7% | 0.00% | -50.0% |
| Q1 2023 | $2,853 | +66.0% | 1,097,348 | +30.9% | 0.00% | +100.0% |
| Q4 2022 | $1,719 | -99.9% | 838,302 | +63.9% | 0.00% | 0.0% |
| Q3 2022 | $2,307,000 | +126.6% | 511,608 | +105.5% | 0.00% | 0.0% |
| Q2 2022 | $1,018,000 | +444.4% | 248,917 | +487.1% | 0.00% | – |
| Q1 2022 | $187,000 | – | 42,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,796,761 | 38.27% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $13,066,725 | 6.41% |
| MPM BioImpact LLC | 2,388,011 | $7,283,434 | 1.47% |
| RA Capital Management | 6,144,881 | $18,741,887 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,911,771 | 0.30% |
| PFM Health Sciences, LP | 2,303,891 | $7,026,868 | 0.27% |
| Rubric Capital Management LP | 1,935,357 | $5,902,839 | 0.25% |
| Alyeska Investment Group, L.P. | 397,808 | $1,213,314 | 0.01% |
| Laurion Capital Management LP | 522,900 | $1,594,845 | 0.01% |
| Schonfeld Strategic Advisors LLC | 326,702 | $996,441 | 0.01% |